Effect of Clemastine Fumarate on Color Vision in Healthy Controls

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2016

Conditions

Healthy Subjects

Interventions

DRUG

Clemastine fumarate

4mg 2x day clemastine fumarate orally.

Trial Locations (1)

Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER

NCT02613091 - Effect of Clemastine Fumarate on Color Vision in Healthy Controls | Biotech Hunter | Biotech Hunter